(Q30408866)

12 October 2017

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy (English)

1 reference

12 October 2017

0 references

1 reference

0 references

6

Siamak Daneshmand

1 reference

12 October 2017

Stephen H Culp

1

1 reference

12 October 2017

Rian J Dickstein

2

1 reference

12 October 2017

H Barton Grossman

3

1 reference

12 October 2017

Shanna M Pretzsch

4

1 reference

12 October 2017

Sima Porten

5

1 reference

12 October 2017

Jie Cai

7

1 reference

12 October 2017

Susan Groshen

8

1 reference

12 October 2017

Arlene Siefker-Radtke

9

1 reference

12 October 2017

Randall E Millikan

10

1 reference

12 October 2017

Bogdan Czerniak

11

1 reference

12 October 2017

Neema Navai

12

1 reference

12 October 2017

Matthew F Wszolek

13

1 reference

12 October 2017

Ashish M Kamat

14

1 reference

12 October 2017

Colin P N Dinney

15

1 reference

12 October 2017

language of work or name

English

0 references

publication date

30 July 2013

1 reference

12 October 2017

1 reference

12 October 2017

191

1 reference

12 October 2017

1

1 reference

12 October 2017

40-47

1 reference

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Preoperative hydronephrosis as an indicator of survival after radical cystectomy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Neoadjuvant chemotherapy for bladder cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158919

The effects of stage divergence on survival after radical cystectomy for urothelial cancer

26 November 2018

1 reference

12 December 2020

Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder

1 reference

12 December 2020

Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era

1 reference

12 December 2020

Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy

1 reference

12 December 2020

Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer

1 reference

12 December 2020

The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer

1 reference

12 December 2020

Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer

1 reference

12 December 2020

Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

1 reference

12 December 2020

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update

1 reference

12 December 2020

Stage B () transitional cell carcinoma of bladder highly curable by radical cystectomy

1 reference

12 December 2020

Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma

1 reference

12 December 2020

Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy

1 reference

12 December 2020

10.1016/J.JURO.2013.07.061

Identifiers

DOI

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

23911605

1 reference